importation of unregistered drug products · sigmapharm labs llc. list of products drug company*...
TRANSCRIPT
Republic of the Philippines Department of Health
Food and Drug Administration
Importation of Unregistered Drug Products
Center for Drug Regulation and Research
Food and Drug Administration
I. Food and Drug Administration
II. Use of Unregistered Products
III. Issues for Discussion
Presentation Outline
5 May 2015 2
Discuss and solicit comments from stakeholders on issues arising from the importation of unregistered drug products
Objective
Republic of the Philippines Department of Health
Food and Drug Administration
Food and Drug Administration
To ensure the safety, efficacy, purity, and quality of products we regulate through effective implementation of the national regulatory framework consistent with international best practice
MISSION 5
To be an internationally recognized center of regulatory excellence safeguarding the health of the Filipinos
VISION 6
QUALITY POLICY
Our highest commitment is to ensure the safety, efficacy and quality of health products.
Toward this end, we commit to establish science-based standards as basis for regulatory policies, to continually improve and maintain our competencies in relation to our regulatory function, and to deliver quality public service with integrity.
7
Regulatory Framework Elements
1. Licensing/Accreditation of establishments • GMP, GDP, GSP, GCP, and GLP
2. Pre-marketing assessment • Quality, safety, and efficacy (for innovative medicines)
• Quality+interchangeability (for generics)
3. Post-marketing surveillance • Safety (benefit/risk balance)
• Quality (quality testing and compliance monitoring)
4. Communication 8
1. Pharmacovigilance
• Safety monitoring of drugs on the market for unexpected health risks and informing the public of risks posed by specific drugs and other health products;
2. Monitoring, collecting, sampling and testing of drugs
3. Audits and inspection of manufacturers/ distributors/ retail outlets
4. Advertisements and claims monitoring
5. Consumer reporting of ADR
6. Product recall / Administrative sanctions
Post-Marketing Surveillance 9
• Regulatory safeguards are in place to protect the public
• Licensing of establishments, registration of products, and post licensing and post marketing surveillance
Summary..
Republic of the Philippines Department of Health
Food and Drug Administration
Use of Unregistered Products
k)a, Sec. 1 General Provision, Article I, Book II
IRR of RA 9711
• FDA recognizes the need for drugs and devices product/preparation which are not registered or are in the process of registration in the Philippines by patients who are terminally or seriously ill.
• Access to these products for these patients is morally, socially and ethically justified when there is no existing superior alternative therapy that can likely cure or adequately control their conditions.
5 May 2015 13
Administrative Order No. 4 s. 1992
5 May 2015 14
AO No. 4 s. 1992
Compassionate Special Permit for Restricted Use of Unregistered Drug and Devices Product (CSP)
• a special permit signed by the FDA Director granting a Specialized Institution (SI) and Specialty Society (SS) the privilege to avail of an unregistered drug and device product through a certain licensed establishment for certain kind/type of patients, specific volume and period.
15 5 May 2015
AO No. 4 s. 1992
• For patients suffering from the following conditions:
1. Acquired Immune Deficiency Syndrome (AIDS)
2. Cancer
3. Life-threatening conditions
5 May 2015 16
Application shall include:
• estimated volume needed
• the licensed drug/ device establishment through which the unregistered drug may be procured
• identify the names and address of the specialists qualified and authorized to use the product
AO No. 4 s. 1992 5 May 2015 17
Drug
Quantity requested per year Frequency of request
2013 2014 Total 2013 2014 Total
Colistimethate Na 1 M Unit vial 7600 37170 44770 13 23 36
Dipyridamole 10mg/2ml ampoule 10333 16382 26715 12 18 30
Glyceryl trinitrate 10mg/10ml amp 14990 9319 24309 8 20 28
Protamine sulfate 50mg/5ml vial 11475 6691 18166 13 22 35
Vasopressin 20 units/ml vial 4425 6895 11320 10 14 24
Adenosine 6mg/2ml vial 3963 5605 9568 15 30 45
Phenylephrine 1% 10mg/1ml vial 2700 4985 7685 9 17 26
Papaverine HCl 30mg/ml, in 2ml vial 1495 2908 4403 8 19 27
Esmolol HCl 10mg/ml, in 10 ml vial 1405 2958 4363 10 21 31
Milrinone lactate 10mg vial 2302 2057 4359 10 14 24
Dantrolene sodium 20mg/65mL vial 408 850 1258 11 20 31
Top Requested Drugs
Drug
Quantity requested per year Frequency of request
2013 2014 Total 2013 2014 Total
Sotalol 80mg tablet 10400 13030 23430 2 2 4
Propafenone 150mg tablet 4400 14500 18900 1 2 3
Liothyronine (Cynomel) 25mcg tablet 7220 7800 15020 4 4 8
Co-trimoxazole (Trimethoprim 16 mg/ml
+ Sulfamethoxazole 80 mg/ml) [Bactrim]
Solution for injection, in 5ml vial
1450 9112 10562 3 8 11
Fludrocortisone 0.1mg tablet 3100 5800 8900 2 4 6
Provocholine nebulization kit 1700 3400 5100 2 2 4
Provocholine 100mg/vial 288 475 763 2 2 4
Top Requested Drugs
Hospitals No. of applications per year
2013 2014 Total
St. Luke's Medical Center – Global City 6 12 18
St. Luke's Medical Center – Quezon City 8 8 16
Cardinal Santos Medical Center 8 7 15
The Medical City 5 7 12
Philippine General Hospital 7 3 10
Makati Medical Center 3 6 9
University of Santo Tomas Hospital 2 6 8
Asian Hospital and Medical Center 2 5 7
Manila Doctors Hospital 2 5 7
Philippine Heart Center 2 2 4
Top Requesting Hospitals
Republic of the Philippines Department of Health
Food and Drug Administration
Issues for Discussion
• Misalignment with AO 4
• Concerns from Hospital Group
• List of Products
Issues for Discussion
• Regular request (from 2 to 12 times a year) for permit to import of unregistered to be used for critical care, strictly for their own use
• Quantity is considered to be substantial
• No specific patients identified
Misalignment with AO 4
• 13 April 2015 – representatives from PHA and PSHP
• Some of the concerns: – Hospitals acknowledge the risks – waiver – No choice – no MAH/importer is willing to
register due to “low volume” = not profitable – Some drugs are included in the PNDF but not
available in the market
Concerns from Hospital Group
List of Products Drug Company*
Phenylephrine 1% 10mg/1ml vial WEST WARD PHARM CORP; ECLAT PHARMS LLC;
Nitroprusside (Nitropress) 50mg/2ml vial HOSPIRA Dantrolene sodium (Revonto) 20mg/65mL vial
US WORLDMEDS PAR STERILE PRODUCTS
Dipyridamole (Persantin) 10mg/2ml ampoule
BEDFORD FRESENIUS KABI USA HIKMA MAPLE
Protamine sulfate 10mg/ml, in 5ml vial FRESENIUS KABI USA Thrombin 5000 units/5ml vial PapaverineHCl30mg/ml, in 2ml vial AMERICAN REGENT, INC. Vasopressin (Pitressin) 20 units/ml vial PAR STERILE PRODUCTS
Colistimethate sodium (Colomycin) 1 Million Unit vial
EMCURE PHARMS LTD; FRESENIUS KABI USA; PADDOCK LLC; AGENT PHARMS; X GEN PHARMS; PAR STERILE PRODUCTS
List of Products Drug Company*
Milrinone lactate 10mg/10ml vial
BEDFORD; FRESENIUS KABI USA; GLAND PHARMA LTD HOSPIRA INC
Ferric subsulfate (Astringyn) topical solution Cooper Surgical
Adenosine (Adenocor) 6mg/2ml vial
AMDIPHARM MERCURY COMPANY LIMITED; FOCUS PHARMACEUTICALS LTD; WOCKHARDT UK LTD
EsmololHCl (Brevibloc) 10mg/ml, in 10 ml
vial
BAXTER HEALTHCARE;
EUROHLTH INTL SAR;
FRESENIUS KABI USA;
LUITPOLD;
MYLAN INSTITUTIONAL
Thiopental sodium 500mg
Powder for Injection Solution, in Vial
ARCHIMEDES PHARMA UK LTD
Ferric subsulfate (Monsel’s) 8 ml Solution Clique Hemostasis Products
List of Products Drug Company*
Lidocaine HCl 2% Jelly USP, 30ml tube
SAGENT PHARMS;
AKORN;
INTL MEDICATION;
WATSON LABS INC;
OAK PHARMS
Streptokinase (Streptase) 1.5 Million units, vial BEACON PHARMACEUTICALS;
CSL BERHING UK LIMITED
Aminocaproic acid 250mg/ml, 20ml vial LUITPOLD;
HOSPIRA
Calcium chloride 100mg/ml, 10ml vial International Medication Systems (UK)
Cyclosporine (Sandimmune) 250mg/5ml
ampoule
Novartis Pharmaceuticals
List of Products Drug Company*
Etomidate (Amidate) 2mg/ml, 10ml vial
HOSPIRA;
AGILA SPECLTS;
BEDFORD;
EMCURE PHARMS LTD;
LUITPOLD;
PAR STERILE PRODUCTS;
ZYDUS PHARMS USA INC
Labetalol HCl injection 100mg/20ml vial
AKORN INC;
EUROHLTH INTL SARL;
GLAND PHARMA LTD;
HOSPIRA
Metolazone 5mg tablet
UCB INC;
SANDOZ;
MYLAN
Pentafluoropropanetetrafluoroethane
(Gebauer'spain Ease) 3.5 Oz Medium Stream
Spray
GABAUER COMPANY
List of Products Drug Company*
Estriol (Ovestin) Vaginal Cream 1mg/g, 15g
tube
ASPEN
Verapamil HCl 2.5mg/ml ampoule ABBOTT
HOSPIRA
Trientinedihydrochloride (Syprine) 300mg
capsule
ATON PHARMA, INC.
Isosorbidedinitrate (Isoket) 0.1% 1mg/ml
ampoule
UCB PHARMA LIMITED
Fludrocortisone 0.1mg tablet E.R. SQUIBB & SONS LIMITED
Sotalol 120mg tablet
COVIS PHARMA SARL;
UPSHER SMITH;
APOTEX;
EPIC PHARMA INC;
IMPAX PHARMS;
MYLAN;
SANDOZ;
TEVA;
VINTAGE
List of Products Drug Company*
Sotalol 80mg tablet
COVIS PHARMA SARL;
UPSHER SMITH;
APOTEX INC;
EPIC PHARMA INC;
IMPAX PHARMS;
MYLAN;
SANDOZ;
TEVA;
VINTAGE
Diltiazem 5mg/ml, 10ml vial
AKORN INC;
BEDFORD;
HIKMA FARMACEUTICA;
HIKMA MAPLE;
List of Products Drug Company*
Irinotecan 100mg/5ml vial
PFIZER INC;
ACCORD HLTHCARE;
ACTAVIS TOTOWA;
AKORN;
BEDFORD LABS;
CIPLA LTD;
DR REDDYS LABS LTD;
EBEWE PHARMA;
EMCURE PHARMS LTD;
FRESENIUS KABI ONCOL;
FRESENIUS KABI USA;
HIKMA FARMACEUTICA;
HISUN PHARM HANGZHOU;
HOSPIRA;
JIANGSU HENGRUI MED;
MUSTAFA NEVZAT ILAC;
PLIVA LACHEMA;
SUN PHARMA GLOBAL;
TEVA PHARMS USA
List of Products Drug Company*
Pentamidine isethionate 300mg vial FRESENIUS KABI USA
Argatroban (Acova) 250mg/2.5ml Single-use
vial
PFIZER;
HIKMA PHARM CO LTD;
MYLAN INSTITUTIONAL;
PAR STERILE PRODUCTS;
FRESENIUS KABI USA
Melphalan 50mg vial ASPEN
Fludarabine (Fludara) 50mg vial SANOFI
Alprostadil (Caverject) 40mcg/ml vial
PFIZER, INC.
PHARMACIA AND UPJOHN;
AUXILIUM PHARMS LLC
Busulfan (Myleran) 2mg tablet ASPEN GLOBAL
Azacitidine 100mg vial DR REDDYS LABS LTD;
CELGENE
List of Products Drug Company*
Naltrexone HCl 50mg tablet
ACCORD HLTHCARE;
BARR;
ELITE LABS;
TEVA WOMENS;
SUN PHARMA GLOBAL;
MALLINCKRODT
Chemet 100mg capsule RECORDATI RARE
Liothyronine (Cynomel) 25mcg tablet
KING PHARMS R AND D;
COASTAL PHARMS;
MYLAN;
SIGMAPHARM LABS LLC
Liothyronine 50mcg tablet
KING PHARMS R AND D;
COASTAL PHARMS;
MYLAN;
SIGMAPHARM LABS LLC
List of Products Drug Company*
Carmustine (BCNU) 100mg vial EMCURE PHARMS LTD
Edrophonium 10mg/ml ampoule MYLAN INSTITUTIONAL
Hydroxyprogesteronecaproate (Proluton depot)
250mg/ml ampoule
LUMARA HEALTH INC
Bendamustine 100mg vial CEPHALON
Propafenone 150mg tablet
ANI PHARMS INC;
MUTUAL PHARM;;
VINTAGE PHARMS
GLAXOSMITHKLINE LLC
Propafenone 300mg tablet
ANI PHARMS INC;
MUTUAL PHARM
VINTAGE PHARMS;
GLAXOSMITHKLINE LLC
Quinidine sulfate 200mg tablet
MUTUAL PHARM;
ATSON LABS;
SANDOZ
List of Products Drug Company*
Potassium acid phosphate 10mmol/10ml
ampoule
MARTINDALE
PHARMACEUTICALS LTD
Sodium tetra decylsulfate (Fibrovein) 3% 2ml
ampoule
STD PHARMACEUTICAL
PRODUCTS LT
Procainamide 100mg/ml, 10ml vial HOSPIRA
Alprostadil 500mcg/ml ampoule
PHARMACIA AND UPJOHN
TEVA PHARMS USA
EUROHLTH INTL SARL
Phentolaminemesylate 10mg/ml ampoule BEDFORD LABORATORIES
SAMARTH PHARMA PVT. LTD.
MidodrineHCl 10mg tablet
APOTEX INC
IMPAX PHARMS
MYLAN PHARMS IN
SANDOZ
UPSHER SMITH
Cinacalcet HCl (Mimpara) 30mg tablet AMGEN
List of Products Drug Company*
Cinacalcet HCl (Mimpara) 60mg tablet AMGEN
Ora-Plus Oral Suspending Vehicle 473ml PADDOCK LABORATORIES
Potassium Iodide (Jodid) 100mcg tablet MERCK
Glycopyrrolate 0.2mg/ml, in 5 ml vial AMDIPHARM MERCURY
COMPANY LIMITED
Fluorescein Injection ALCON LABORATORIES UK
LIMITED
Glyceryl trinitrate 10mg/10ml ampoule
LUITPOLD; HAMELN PHARMA
PLUS GMBH; MERCURY PHARMA
INTERNATIONAL LTD
Rho(D) Immune Globulin Intravenous Human
1500 IU (300mcg) per 3ml, lyophilized
powder for injection, in vial
JOHNSON & JOHNSON
Isoproterenol (Isoprenaline) 0.2mg/ml, 1ml
ampoule
HOSPIRA
List of Products Drug Company*
Co-trimoxazole (Trimethoprim 16 mg/ml +
Sulfamethoxazole 80 mg/ml) [Bactrim]
Solution for injection, in 5ml vial
INTERNATIONAL APEX
PHARMACEUTICALS, INC.
MUTUAL PHARM
Metolazone 2mg tablet SANDOZ
Dantrolene sodium 20mg tablet PAR STERILE PRODUCTS
NORGINE LIMITED
IMPAX LABS
MIKAH PHARMA
Provocholine 100mg/vial METHAPHARM INC.
Provocholine nebulization kit METHAPHARM INC.
• Foreign supplier has local counterpart, yet products are not registered due to “low demand”
List of Products
• Mandatory registration will be required for the products – MAH will have prioritized review – Pending applications of CSP may be granted one
last time
Recommendations